Challenges and Hallmarks of Establishing Alkylacetylphosphonates as Probes of Bacterial 1-Deoxy- d -xylulose 5-Phosphate Synthase

Sara Sanders, Ryan J. Vierling, David Bartee, Alicia A. Decolli, Mackenzie J. Harrison, Joseph L. Aklinski, Andrew T Koppisch, Caren L. Freel Meyers

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

1-Deoxy-d-xylulose 5-phosphate (DXP) synthase catalyzes the thiamin diphosphate (ThDP)-dependent formation of DXP from pyruvate and d-glyceraldehyde 3-phosphate. DXP is at a metabolic branch point in bacteria, feeding into the methylerythritol phosphate pathway to indispensable isoprenoids and acting as a precursor for biosynthesis of essential cofactors in central metabolism, pyridoxal phosphate and ThDP, the latter of which is also required for DXP synthase catalysis. DXP synthase follows a unique random sequential mechanism and possesses an unusually large active site. These features have guided the design of sterically demanding alkylacetylphosphonates (alkylAPs) toward the development of selective DXP synthase inhibitors. alkylAPs studied here display selective, low μM inhibitory activity against DXP synthase. They are weak inhibitors of bacterial growth in standard nutrient rich conditions. However, bacteria are significantly sensitized to most alkylAPs in defined minimal growth medium, with minimal inhibitory concentrations (MICs) ranging from low μM to low mM and influenced by alkyl-chain length. The longest analog (C8) displays the weakest antimicrobial activity and is a substrate for efflux via AcrAB-TolC. The dependence of inhibitor potency on growth environment emphasizes the need for antimicrobial screening conditions that are relevant to the in vivo microbial microenvironment during infection. DXP synthase expression and thiamin supplementation studies offer support for DXP synthase as an intracellular target for some alkylAPs and reveal both the challenges and intriguing aspects of these approaches to study target engagement.

Original languageEnglish (US)
Pages (from-to)467-478
Number of pages12
JournalACS Infectious Diseases
Volume3
Issue number7
DOIs
StatePublished - Jul 14 2017

Fingerprint

Thiamine Pyrophosphate
Glyceraldehyde 3-Phosphate
Bacteria
xylulose-5-phosphate
Growth Inhibitors
Pyridoxal Phosphate
Thiamine
Terpenes
Growth
Catalysis
Pyruvic Acid
Catalytic Domain
Phosphates
Food
Infection
pyridoxal diphosphate

Keywords

  • 1-deoxy- d -xylulose 5-phosphate synthase
  • bacterial metabolic branch point
  • growth medium effect
  • isoprenoid biosynthesis
  • PLP biosynthesis
  • thiamin biosynthesis

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Sanders, S., Vierling, R. J., Bartee, D., Decolli, A. A., Harrison, M. J., Aklinski, J. L., ... Freel Meyers, C. L. (2017). Challenges and Hallmarks of Establishing Alkylacetylphosphonates as Probes of Bacterial 1-Deoxy- d -xylulose 5-Phosphate Synthase. ACS Infectious Diseases, 3(7), 467-478. https://doi.org/10.1021/acsinfecdis.6b00168

Challenges and Hallmarks of Establishing Alkylacetylphosphonates as Probes of Bacterial 1-Deoxy- d -xylulose 5-Phosphate Synthase. / Sanders, Sara; Vierling, Ryan J.; Bartee, David; Decolli, Alicia A.; Harrison, Mackenzie J.; Aklinski, Joseph L.; Koppisch, Andrew T; Freel Meyers, Caren L.

In: ACS Infectious Diseases, Vol. 3, No. 7, 14.07.2017, p. 467-478.

Research output: Contribution to journalArticle

Sanders, Sara ; Vierling, Ryan J. ; Bartee, David ; Decolli, Alicia A. ; Harrison, Mackenzie J. ; Aklinski, Joseph L. ; Koppisch, Andrew T ; Freel Meyers, Caren L. / Challenges and Hallmarks of Establishing Alkylacetylphosphonates as Probes of Bacterial 1-Deoxy- d -xylulose 5-Phosphate Synthase. In: ACS Infectious Diseases. 2017 ; Vol. 3, No. 7. pp. 467-478.
@article{79b3b72ea379479dbb02be8bf8ec9460,
title = "Challenges and Hallmarks of Establishing Alkylacetylphosphonates as Probes of Bacterial 1-Deoxy- d -xylulose 5-Phosphate Synthase",
abstract = "1-Deoxy-d-xylulose 5-phosphate (DXP) synthase catalyzes the thiamin diphosphate (ThDP)-dependent formation of DXP from pyruvate and d-glyceraldehyde 3-phosphate. DXP is at a metabolic branch point in bacteria, feeding into the methylerythritol phosphate pathway to indispensable isoprenoids and acting as a precursor for biosynthesis of essential cofactors in central metabolism, pyridoxal phosphate and ThDP, the latter of which is also required for DXP synthase catalysis. DXP synthase follows a unique random sequential mechanism and possesses an unusually large active site. These features have guided the design of sterically demanding alkylacetylphosphonates (alkylAPs) toward the development of selective DXP synthase inhibitors. alkylAPs studied here display selective, low μM inhibitory activity against DXP synthase. They are weak inhibitors of bacterial growth in standard nutrient rich conditions. However, bacteria are significantly sensitized to most alkylAPs in defined minimal growth medium, with minimal inhibitory concentrations (MICs) ranging from low μM to low mM and influenced by alkyl-chain length. The longest analog (C8) displays the weakest antimicrobial activity and is a substrate for efflux via AcrAB-TolC. The dependence of inhibitor potency on growth environment emphasizes the need for antimicrobial screening conditions that are relevant to the in vivo microbial microenvironment during infection. DXP synthase expression and thiamin supplementation studies offer support for DXP synthase as an intracellular target for some alkylAPs and reveal both the challenges and intriguing aspects of these approaches to study target engagement.",
keywords = "1-deoxy- d -xylulose 5-phosphate synthase, bacterial metabolic branch point, growth medium effect, isoprenoid biosynthesis, PLP biosynthesis, thiamin biosynthesis",
author = "Sara Sanders and Vierling, {Ryan J.} and David Bartee and Decolli, {Alicia A.} and Harrison, {Mackenzie J.} and Aklinski, {Joseph L.} and Koppisch, {Andrew T} and {Freel Meyers}, {Caren L.}",
year = "2017",
month = "7",
day = "14",
doi = "10.1021/acsinfecdis.6b00168",
language = "English (US)",
volume = "3",
pages = "467--478",
journal = "ACS Infectious Diseases",
issn = "2373-8227",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Challenges and Hallmarks of Establishing Alkylacetylphosphonates as Probes of Bacterial 1-Deoxy- d -xylulose 5-Phosphate Synthase

AU - Sanders, Sara

AU - Vierling, Ryan J.

AU - Bartee, David

AU - Decolli, Alicia A.

AU - Harrison, Mackenzie J.

AU - Aklinski, Joseph L.

AU - Koppisch, Andrew T

AU - Freel Meyers, Caren L.

PY - 2017/7/14

Y1 - 2017/7/14

N2 - 1-Deoxy-d-xylulose 5-phosphate (DXP) synthase catalyzes the thiamin diphosphate (ThDP)-dependent formation of DXP from pyruvate and d-glyceraldehyde 3-phosphate. DXP is at a metabolic branch point in bacteria, feeding into the methylerythritol phosphate pathway to indispensable isoprenoids and acting as a precursor for biosynthesis of essential cofactors in central metabolism, pyridoxal phosphate and ThDP, the latter of which is also required for DXP synthase catalysis. DXP synthase follows a unique random sequential mechanism and possesses an unusually large active site. These features have guided the design of sterically demanding alkylacetylphosphonates (alkylAPs) toward the development of selective DXP synthase inhibitors. alkylAPs studied here display selective, low μM inhibitory activity against DXP synthase. They are weak inhibitors of bacterial growth in standard nutrient rich conditions. However, bacteria are significantly sensitized to most alkylAPs in defined minimal growth medium, with minimal inhibitory concentrations (MICs) ranging from low μM to low mM and influenced by alkyl-chain length. The longest analog (C8) displays the weakest antimicrobial activity and is a substrate for efflux via AcrAB-TolC. The dependence of inhibitor potency on growth environment emphasizes the need for antimicrobial screening conditions that are relevant to the in vivo microbial microenvironment during infection. DXP synthase expression and thiamin supplementation studies offer support for DXP synthase as an intracellular target for some alkylAPs and reveal both the challenges and intriguing aspects of these approaches to study target engagement.

AB - 1-Deoxy-d-xylulose 5-phosphate (DXP) synthase catalyzes the thiamin diphosphate (ThDP)-dependent formation of DXP from pyruvate and d-glyceraldehyde 3-phosphate. DXP is at a metabolic branch point in bacteria, feeding into the methylerythritol phosphate pathway to indispensable isoprenoids and acting as a precursor for biosynthesis of essential cofactors in central metabolism, pyridoxal phosphate and ThDP, the latter of which is also required for DXP synthase catalysis. DXP synthase follows a unique random sequential mechanism and possesses an unusually large active site. These features have guided the design of sterically demanding alkylacetylphosphonates (alkylAPs) toward the development of selective DXP synthase inhibitors. alkylAPs studied here display selective, low μM inhibitory activity against DXP synthase. They are weak inhibitors of bacterial growth in standard nutrient rich conditions. However, bacteria are significantly sensitized to most alkylAPs in defined minimal growth medium, with minimal inhibitory concentrations (MICs) ranging from low μM to low mM and influenced by alkyl-chain length. The longest analog (C8) displays the weakest antimicrobial activity and is a substrate for efflux via AcrAB-TolC. The dependence of inhibitor potency on growth environment emphasizes the need for antimicrobial screening conditions that are relevant to the in vivo microbial microenvironment during infection. DXP synthase expression and thiamin supplementation studies offer support for DXP synthase as an intracellular target for some alkylAPs and reveal both the challenges and intriguing aspects of these approaches to study target engagement.

KW - 1-deoxy- d -xylulose 5-phosphate synthase

KW - bacterial metabolic branch point

KW - growth medium effect

KW - isoprenoid biosynthesis

KW - PLP biosynthesis

KW - thiamin biosynthesis

UR - http://www.scopus.com/inward/record.url?scp=85023763745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023763745&partnerID=8YFLogxK

U2 - 10.1021/acsinfecdis.6b00168

DO - 10.1021/acsinfecdis.6b00168

M3 - Article

VL - 3

SP - 467

EP - 478

JO - ACS Infectious Diseases

JF - ACS Infectious Diseases

SN - 2373-8227

IS - 7

ER -